• Vaxil Locations
  • Contact Us
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • PIPELINE
  • News and Updates
  • Presentation
  • Covid-19 experiments
  • In the Media

Category Archives: Annnouncements

24 Nov
Annnouncements

VAXIL ANNOUNCES CLOSE OF FIRST TRANCHE OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT FOR GROSS PROCEEDS OF $542,858

… Read the rest
Posted on November 24, 2020 by David Goren
10 Nov
Annnouncements

VAXIL ANNOUNCES NON-BROKERED PRIVATE PLACEMENT

… Read the rest
Posted on November 10, 2020 by David Goren
13 Oct
Annnouncements

VAXIL INITIATES PRE-CLINICAL STUDY IN NEW ONCOLOGY TARGET

… Read the rest
Posted on October 13, 2020 by David Goren
17 Sep
Annnouncements

VAXIL PROVIDES UPDATE OF CONVERSION OF PREVIOUSLY ISSUED CONVERTIBLE DEBT AND THE GRANTING OF OPTIONS

… Read the rest
Posted on September 17, 2020October 1, 2020 by David Goren
08 Sep
Annnouncements

VAXIL ANNOUNCES POSITIVE RESULTS ON CorVax™ IN VIVO STUDY

… Read the rest
Posted on September 8, 2020September 8, 2020 by David Goren
Older posts
Newer posts

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, Weizmann Science Park, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Presentations
  • Public Filings
  • News and Updates
  • In the Media
  • Video
  • Scientific Publications
Copyright 2021 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • PIPELINE
  • News and Updates
  • Presentation
  • Covid-19 experiments
  • In the Media
  • Vaxil Locations
  • Contact Us
  • Subscribe